- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
The Biosimilars/Follow-on-Biologics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Biosimilars/Follow-on-Biologics market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Blood Disorders accounting for % of the Biosimilars/Follow-on-Biologics global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Human Growth Hormone segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Biosimilars/Follow-on-Biologics include Novartis, Synthon Pharmaceuticals, Teva Pharmaceutical Industries, LG Life Sciences, and Celltrion, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Biosimilars/Follow-on-Biologics market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Human Growth Hormone
Erythropoietin
Monoclonal Antibodies
Insulin
Interferon
Granulocyte-Colony Stimulating Factor
Peptide
Others
Market segment by Application can be divided into
Blood Disorders
Oncology Diseases
Chronic and Autoimmune Diseases
Growth Hormone Deficiencies
Others
The key market players for global Biosimilars/Follow-on-Biologics market are listed below:
Novartis
Synthon Pharmaceuticals
Teva Pharmaceutical Industries
LG Life Sciences
Celltrion
Biocon
Hospira
Merck Group
Biogen idec, Inc.
Genentech (Roche Group)
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Biosimilars/Follow-on-Biologics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Biosimilars/Follow-on-Biologics, with price, sales, revenue and global market share of Biosimilars/Follow-on-Biologics from 2019 to 2022.
Chapter 3, the Biosimilars/Follow-on-Biologics competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biosimilars/Follow-on-Biologics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Biosimilars/Follow-on-Biologics market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Biosimilars/Follow-on-Biologics.
Chapter 13, 14, and 15, to describe Biosimilars/Follow-on-Biologics sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Biosimilars/Follow-on-Biologics Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Biosimilars/Follow-on-Biologics Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Human Growth Hormone
1.2.3 Erythropoietin
1.2.4 Monoclonal Antibodies
1.2.5 Insulin
1.2.6 Interferon
1.2.7 Granulocyte-Colony Stimulating Factor
1.2.8 Peptide
1.2.9 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Biosimilars/Follow-on-Biologics Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Blood Disorders
1.3.3 Oncology Diseases
1.3.4 Chronic and Autoimmune Diseases
1.3.5 Growth Hormone Deficiencies
1.3.6 Others
1.4 Global Biosimilars/Follow-on-Biologics Market Size & Forecast
1.4.1 Global Biosimilars/Follow-on-Biologics Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Biosimilars/Follow-on-Biologics Sales in Volume (2017-2028)
1.4.3 Global Biosimilars/Follow-on-Biologics Price (2017-2028)
1.5 Global Biosimilars/Follow-on-Biologics Production Capacity Analysis
1.5.1 Global Biosimilars/Follow-on-Biologics Total Production Capacity (2017-2028)
1.5.2 Global Biosimilars/Follow-on-Biologics Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Biosimilars/Follow-on-Biologics Market Drivers
1.6.2 Biosimilars/Follow-on-Biologics Market Restraints
1.6.3 Biosimilars/Follow-on-Biologics Trends Analysis
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Biosimilars/Follow-on-Biologics Product and Services
2.1.4 Novartis Biosimilars/Follow-on-Biologics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Synthon Pharmaceuticals
2.2.1 Synthon Pharmaceuticals Details
2.2.2 Synthon Pharmaceuticals Major Business
2.2.3 Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Product and Services
2.2.4 Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Teva Pharmaceutical Industries
2.3.1 Teva Pharmaceutical Industries Details
2.3.2 Teva Pharmaceutical Industries Major Business
2.3.3 Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Product and Services
2.3.4 Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 LG Life Sciences
2.4.1 LG Life Sciences Details
2.4.2 LG Life Sciences Major Business
2.4.3 LG Life Sciences Biosimilars/Follow-on-Biologics Product and Services
2.4.4 LG Life Sciences Biosimilars/Follow-on-Biologics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Celltrion
2.5.1 Celltrion Details
2.5.2 Celltrion Major Business
2.5.3 Celltrion Biosimilars/Follow-on-Biologics Product and Services
2.5.4 Celltrion Biosimilars/Follow-on-Biologics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Biocon
2.6.1 Biocon Details
2.6.2 Biocon Major Business
2.6.3 Biocon Biosimilars/Follow-on-Biologics Product and Services
2.6.4 Biocon Biosimilars/Follow-on-Biologics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Hospira
2.7.1 Hospira Details
2.7.2 Hospira Major Business
2.7.3 Hospira Biosimilars/Follow-on-Biologics Product and Services
2.7.4 Hospira Biosimilars/Follow-on-Biologics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Merck Group
2.8.1 Merck Group Details
2.8.2 Merck Group Major Business
2.8.3 Merck Group Biosimilars/Follow-on-Biologics Product and Services
2.8.4 Merck Group Biosimilars/Follow-on-Biologics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Biogen idec, Inc.
2.9.1 Biogen idec, Inc. Details
2.9.2 Biogen idec, Inc. Major Business
2.9.3 Biogen idec, Inc. Biosimilars/Follow-on-Biologics Product and Services
2.9.4 Biogen idec, Inc. Biosimilars/Follow-on-Biologics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Genentech (Roche Group)
2.10.1 Genentech (Roche Group) Details
2.10.2 Genentech (Roche Group) Major Business
2.10.3 Genentech (Roche Group) Biosimilars/Follow-on-Biologics Product and Services
2.10.4 Genentech (Roche Group) Biosimilars/Follow-on-Biologics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Biosimilars/Follow-on-Biologics Breakdown Data by Manufacturer
3.1 Global Biosimilars/Follow-on-Biologics Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Biosimilars/Follow-on-Biologics Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Biosimilars/Follow-on-Biologics
3.4 Market Concentration Rate
3.4.1 Top 3 Biosimilars/Follow-on-Biologics Manufacturer Market Share in 2021
3.4.2 Top 6 Biosimilars/Follow-on-Biologics Manufacturer Market Share in 2021
3.5 Global Biosimilars/Follow-on-Biologics Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Biosimilars/Follow-on-Biologics Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Biosimilars/Follow-on-Biologics Market Size by Region
4.1.1 Global Biosimilars/Follow-on-Biologics Sales in Volume by Region (2017-2028)
4.1.2 Global Biosimilars/Follow-on-Biologics Revenue by Region (2017-2028)
4.2 North America Biosimilars/Follow-on-Biologics Revenue (2017-2028)
4.3 Europe Biosimilars/Follow-on-Biologics Revenue (2017-2028)
4.4 Asia-Pacific Biosimilars/Follow-on-Biologics Revenue (2017-2028)
4.5 South America Biosimilars/Follow-on-Biologics Revenue (2017-2028)
4.6 Middle East and Africa Biosimilars/Follow-on-Biologics Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Biosimilars/Follow-on-Biologics Sales in Volume by Type (2017-2028)
5.2 Global Biosimilars/Follow-on-Biologics Revenue by Type (2017-2028)
5.3 Global Biosimilars/Follow-on-Biologics Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Biosimilars/Follow-on-Biologics Sales in Volume by Application (2017-2028)
6.2 Global Biosimilars/Follow-on-Biologics Revenue by Application (2017-2028)
6.3 Global Biosimilars/Follow-on-Biologics Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Biosimilars/Follow-on-Biologics Sales by Type (2017-2028)
7.2 North America Biosimilars/Follow-on-Biologics Sales by Application (2017-2028)
7.3 North America Biosimilars/Follow-on-Biologics Market Size by Country
7.3.1 North America Biosimilars/Follow-on-Biologics Sales in Volume by Country (2017-2028)
7.3.2 North America Biosimilars/Follow-on-Biologics Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Biosimilars/Follow-on-Biologics Sales by Type (2017-2028)
8.2 Europe Biosimilars/Follow-on-Biologics Sales by Application (2017-2028)
8.3 Europe Biosimilars/Follow-on-Biologics Market Size by Country
8.3.1 Europe Biosimilars/Follow-on-Biologics Sales in Volume by Country (2017-2028)
8.3.2 Europe Biosimilars/Follow-on-Biologics Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Biosimilars/Follow-on-Biologics Sales by Type (2017-2028)
9.2 Asia-Pacific Biosimilars/Follow-on-Biologics Sales by Application (2017-2028)
9.3 Asia-Pacific Biosimilars/Follow-on-Biologics Market Size by Region
9.3.1 Asia-Pacific Biosimilars/Follow-on-Biologics Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Biosimilars/Follow-on-Biologics Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Biosimilars/Follow-on-Biologics Sales by Type (2017-2028)
10.2 South America Biosimilars/Follow-on-Biologics Sales by Application (2017-2028)
10.3 South America Biosimilars/Follow-on-Biologics Market Size by Country
10.3.1 South America Biosimilars/Follow-on-Biologics Sales in Volume by Country (2017-2028)
10.3.2 South America Biosimilars/Follow-on-Biologics Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Biosimilars/Follow-on-Biologics Sales by Type (2017-2028)
11.2 Middle East & Africa Biosimilars/Follow-on-Biologics Sales by Application (2017-2028)
11.3 Middle East & Africa Biosimilars/Follow-on-Biologics Market Size by Country
11.3.1 Middle East & Africa Biosimilars/Follow-on-Biologics Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Biosimilars/Follow-on-Biologics Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Biosimilars/Follow-on-Biologics and Key Manufacturers
12.2 Manufacturing Costs Percentage of Biosimilars/Follow-on-Biologics
12.3 Biosimilars/Follow-on-Biologics Production Process
12.4 Biosimilars/Follow-on-Biologics Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Biosimilars/Follow-on-Biologics Typical Distributors
13.3 Biosimilars/Follow-on-Biologics Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Biosimilars/Follow-on-Biologics Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Biosimilars/Follow-on-Biologics Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Novartis Basic Information, Manufacturing Base and Competitors
Table 4. Novartis Major Business
Table 5. Novartis Biosimilars/Follow-on-Biologics Product and Services
Table 6. Novartis Biosimilars/Follow-on-Biologics Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Synthon Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 8. Synthon Pharmaceuticals Major Business
Table 9. Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Product and Services
Table 10. Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 12. Teva Pharmaceutical Industries Major Business
Table 13. Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Product and Services
Table 14. Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. LG Life Sciences Basic Information, Manufacturing Base and Competitors
Table 16. LG Life Sciences Major Business
Table 17. LG Life Sciences Biosimilars/Follow-on-Biologics Product and Services
Table 18. LG Life Sciences Biosimilars/Follow-on-Biologics Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Celltrion Basic Information, Manufacturing Base and Competitors
Table 20. Celltrion Major Business
Table 21. Celltrion Biosimilars/Follow-on-Biologics Product and Services
Table 22. Celltrion Biosimilars/Follow-on-Biologics Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Biocon Basic Information, Manufacturing Base and Competitors
Table 24. Biocon Major Business
Table 25. Biocon Biosimilars/Follow-on-Biologics Product and Services
Table 26. Biocon Biosimilars/Follow-on-Biologics Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Hospira Basic Information, Manufacturing Base and Competitors
Table 28. Hospira Major Business
Table 29. Hospira Biosimilars/Follow-on-Biologics Product and Services
Table 30. Hospira Biosimilars/Follow-on-Biologics Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Merck Group Basic Information, Manufacturing Base and Competitors
Table 32. Merck Group Major Business
Table 33. Merck Group Biosimilars/Follow-on-Biologics Product and Services
Table 34. Merck Group Biosimilars/Follow-on-Biologics Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Biogen idec, Inc. Basic Information, Manufacturing Base and Competitors
Table 36. Biogen idec, Inc. Major Business
Table 37. Biogen idec, Inc. Biosimilars/Follow-on-Biologics Product and Services
Table 38. Biogen idec, Inc. Biosimilars/Follow-on-Biologics Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Genentech (Roche Group) Basic Information, Manufacturing Base and Competitors
Table 40. Genentech (Roche Group) Major Business
Table 41. Genentech (Roche Group) Biosimilars/Follow-on-Biologics Product and Services
Table 42. Genentech (Roche Group) Biosimilars/Follow-on-Biologics Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Global Biosimilars/Follow-on-Biologics Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Pcs)
Table 44. Global Biosimilars/Follow-on-Biologics Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 45. Market Position of Manufacturers in Biosimilars/Follow-on-Biologics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 46. Global Biosimilars/Follow-on-Biologics Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 47. Head Office and Biosimilars/Follow-on-Biologics Production Site of Key Manufacturer
Table 48. Biosimilars/Follow-on-Biologics New Entrant and Capacity Expansion Plans
Table 49. Biosimilars/Follow-on-Biologics Mergers & Acquisitions in the Past Five Years
Table 50. Global Biosimilars/Follow-on-Biologics Sales by Region (2017-2022) & (K Pcs)
Table 51. Global Biosimilars/Follow-on-Biologics Sales by Region (2023-2028) & (K Pcs)
Table 52. Global Biosimilars/Follow-on-Biologics Revenue by Region (2017-2022) & (USD Million)
Table 53. Global Biosimilars/Follow-on-Biologics Revenue by Region (2023-2028) & (USD Million)
Table 54. Global Biosimilars/Follow-on-Biologics Sales by Type (2017-2022) & (K Pcs)
Table 55. Global Biosimilars/Follow-on-Biologics Sales by Type (2023-2028) & (K Pcs)
Table 56. Global Biosimilars/Follow-on-Biologics Revenue by Type (2017-2022) & (USD Million)
Table 57. Global Biosimilars/Follow-on-Biologics Revenue by Type (2023-2028) & (USD Million)
Table 58. Global Biosimilars/Follow-on-Biologics Price by Type (2017-2022) & (USD/Pcs)
Table 59. Global Biosimilars/Follow-on-Biologics Price by Type (2023-2028) & (USD/Pcs)
Table 60. Global Biosimilars/Follow-on-Biologics Sales by Application (2017-2022) & (K Pcs)
Table 61. Global Biosimilars/Follow-on-Biologics Sales by Application (2023-2028) & (K Pcs)
Table 62. Global Biosimilars/Follow-on-Biologics Revenue by Application (2017-2022) & (USD Million)
Table 63. Global Biosimilars/Follow-on-Biologics Revenue by Application (2023-2028) & (USD Million)
Table 64. Global Biosimilars/Follow-on-Biologics Price by Application (2017-2022) & (USD/Pcs)
Table 65. Global Biosimilars/Follow-on-Biologics Price by Application (2023-2028) & (USD/Pcs)
Table 66. North America Biosimilars/Follow-on-Biologics Sales by Country (2017-2022) & (K Pcs)
Table 67. North America Biosimilars/Follow-on-Biologics Sales by Country (2023-2028) & (K Pcs)
Table 68. North America Biosimilars/Follow-on-Biologics Revenue by Country (2017-2022) & (USD Million)
Table 69. North America Biosimilars/Follow-on-Biologics Revenue by Country (2023-2028) & (USD Million)
Table 70. North America Biosimilars/Follow-on-Biologics Sales by Type (2017-2022) & (K Pcs)
Table 71. North America Biosimilars/Follow-on-Biologics Sales by Type (2023-2028) & (K Pcs)
Table 72. North America Biosimilars/Follow-on-Biologics Sales by Application (2017-2022) & (K Pcs)
Table 73. North America Biosimilars/Follow-on-Biologics Sales by Application (2023-2028) & (K Pcs)
Table 74. Europe Biosimilars/Follow-on-Biologics Sales by Country (2017-2022) & (K Pcs)
Table 75. Europe Biosimilars/Follow-on-Biologics Sales by Country (2023-2028) & (K Pcs)
Table 76. Europe Biosimilars/Follow-on-Biologics Revenue by Country (2017-2022) & (USD Million)
Table 77. Europe Biosimilars/Follow-on-Biologics Revenue by Country (2023-2028) & (USD Million)
Table 78. Europe Biosimilars/Follow-on-Biologics Sales by Type (2017-2022) & (K Pcs)
Table 79. Europe Biosimilars/Follow-on-Biologics Sales by Type (2023-2028) & (K Pcs)
Table 80. Europe Biosimilars/Follow-on-Biologics Sales by Application (2017-2022) & (K Pcs)
Table 81. Europe Biosimilars/Follow-on-Biologics Sales by Application (2023-2028) & (K Pcs)
Table 82. Asia-Pacific Biosimilars/Follow-on-Biologics Sales by Region (2017-2022) & (K Pcs)
Table 83. Asia-Pacific Biosimilars/Follow-on-Biologics Sales by Region (2023-2028) & (K Pcs)
Table 84. Asia-Pacific Biosimilars/Follow-on-Biologics Revenue by Region (2017-2022) & (USD Million)
Table 85. Asia-Pacific Biosimilars/Follow-on-Biologics Revenue by Region (2023-2028) & (USD Million)
Table 86. Asia-Pacific Biosimilars/Follow-on-Biologics Sales by Type (2017-2022) & (K Pcs)
Table 87. Asia-Pacific Biosimilars/Follow-on-Biologics Sales by Type (2023-2028) & (K Pcs)
Table 88. Asia-Pacific Biosimilars/Follow-on-Biologics Sales by Application (2017-2022) & (K Pcs)
Table 89. Asia-Pacific Biosimilars/Follow-on-Biologics Sales by Application (2023-2028) & (K Pcs)
Table 90. South America Biosimilars/Follow-on-Biologics Sales by Country (2017-2022) & (K Pcs)
Table 91. South America Biosimilars/Follow-on-Biologics Sales by Country (2023-2028) & (K Pcs)
Table 92. South America Biosimilars/Follow-on-Biologics Revenue by Country (2017-2022) & (USD Million)
Table 93. South America Biosimilars/Follow-on-Biologics Revenue by Country (2023-2028) & (USD Million)
Table 94. South America Biosimilars/Follow-on-Biologics Sales by Type (2017-2022) & (K Pcs)
Table 95. South America Biosimilars/Follow-on-Biologics Sales by Type (2023-2028) & (K Pcs)
Table 96. South America Biosimilars/Follow-on-Biologics Sales by Application (2017-2022) & (K Pcs)
Table 97. South America Biosimilars/Follow-on-Biologics Sales by Application (2023-2028) & (K Pcs)
Table 98. Middle East & Africa Biosimilars/Follow-on-Biologics Sales by Region (2017-2022) & (K Pcs)
Table 99. Middle East & Africa Biosimilars/Follow-on-Biologics Sales by Region (2023-2028) & (K Pcs)
Table 100. Middle East & Africa Biosimilars/Follow-on-Biologics Revenue by Region (2017-2022) & (USD Million)
Table 101. Middle East & Africa Biosimilars/Follow-on-Biologics Revenue by Region (2023-2028) & (USD Million)
Table 102. Middle East & Africa Biosimilars/Follow-on-Biologics Sales by Type (2017-2022) & (K Pcs)
Table 103. Middle East & Africa Biosimilars/Follow-on-Biologics Sales by Type (2023-2028) & (K Pcs)
Table 104. Middle East & Africa Biosimilars/Follow-on-Biologics Sales by Application (2017-2022) & (K Pcs)
Table 105. Middle East & Africa Biosimilars/Follow-on-Biologics Sales by Application (2023-2028) & (K Pcs)
Table 106. Biosimilars/Follow-on-Biologics Raw Material
Table 107. Key Manufacturers of Biosimilars/Follow-on-Biologics Raw Materials
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Biosimilars/Follow-on-Biologics Typical Distributors
Table 111. Biosimilars/Follow-on-Biologics Typical Customers
List of Figures
Figure 1. Biosimilars/Follow-on-Biologics Picture
Figure 2. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Type in 2021
Figure 3. Human Growth Hormone
Figure 4. Erythropoietin
Figure 5. Monoclonal Antibodies
Figure 6. Insulin
Figure 7. Interferon
Figure 8. Granulocyte-Colony Stimulating Factor
Figure 9. Peptide
Figure 10. Others
Figure 11. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Application in 2021
Figure 12. Blood Disorders
Figure 13. Oncology Diseases
Figure 14. Chronic and Autoimmune Diseases
Figure 15. Growth Hormone Deficiencies
Figure 16. Others
Figure 17. Global Biosimilars/Follow-on-Biologics Revenue, (USD Million) & (K Pcs): 2017 & 2021 & 2028
Figure 18. Global Biosimilars/Follow-on-Biologics Revenue and Forecast (2017-2028) & (USD Million)
Figure 19. Global Biosimilars/Follow-on-Biologics Sales (2017-2028) & (K Pcs)
Figure 20. Global Biosimilars/Follow-on-Biologics Price (2017-2028) & (USD/Pcs)
Figure 21. Global Biosimilars/Follow-on-Biologics Production Capacity (2017-2028) & (K Pcs)
Figure 22. Global Biosimilars/Follow-on-Biologics Production Capacity by Geographic Region: 2022 VS 2028
Figure 23. Biosimilars/Follow-on-Biologics Market Drivers
Figure 24. Biosimilars/Follow-on-Biologics Market Restraints
Figure 25. Biosimilars/Follow-on-Biologics Market Trends
Figure 26. Global Biosimilars/Follow-on-Biologics Sales Market Share by Manufacturer in 2021
Figure 27. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Manufacturer in 2021
Figure 28. Biosimilars/Follow-on-Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 29. Top 3 Biosimilars/Follow-on-Biologics Manufacturer (Revenue) Market Share in 2021
Figure 30. Top 6 Biosimilars/Follow-on-Biologics Manufacturer (Revenue) Market Share in 2021
Figure 31. Global Biosimilars/Follow-on-Biologics Sales Market Share by Region (2017-2028)
Figure 32. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Region (2017-2028)
Figure 33. North America Biosimilars/Follow-on-Biologics Revenue (2017-2028) & (USD Million)
Figure 34. Europe Biosimilars/Follow-on-Biologics Revenue (2017-2028) & (USD Million)
Figure 35. Asia-Pacific Biosimilars/Follow-on-Biologics Revenue (2017-2028) & (USD Million)
Figure 36. South America Biosimilars/Follow-on-Biologics Revenue (2017-2028) & (USD Million)
Figure 37. Middle East & Africa Biosimilars/Follow-on-Biologics Revenue (2017-2028) & (USD Million)
Figure 38. Global Biosimilars/Follow-on-Biologics Sales Market Share by Type (2017-2028)
Figure 39. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Type (2017-2028)
Figure 40. Global Biosimilars/Follow-on-Biologics Price by Type (2017-2028) & (USD/Pcs)
Figure 41. Global Biosimilars/Follow-on-Biologics Sales Market Share by Application (2017-2028)
Figure 42. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Application (2017-2028)
Figure 43. Global Biosimilars/Follow-on-Biologics Price by Application (2017-2028) & (USD/Pcs)
Figure 44. North America Biosimilars/Follow-on-Biologics Sales Market Share by Type (2017-2028)
Figure 45. North America Biosimilars/Follow-on-Biologics Sales Market Share by Application (2017-2028)
Figure 46. North America Biosimilars/Follow-on-Biologics Sales Market Share by Country (2017-2028)
Figure 47. North America Biosimilars/Follow-on-Biologics Revenue Market Share by Country (2017-2028)
Figure 48. United States Biosimilars/Follow-on-Biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Canada Biosimilars/Follow-on-Biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Mexico Biosimilars/Follow-on-Biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Europe Biosimilars/Follow-on-Biologics Sales Market Share by Type (2017-2028)
Figure 52. Europe Biosimilars/Follow-on-Biologics Sales Market Share by Application (2017-2028)
Figure 53. Europe Biosimilars/Follow-on-Biologics Sales Market Share by Country (2017-2028)
Figure 54. Europe Biosimilars/Follow-on-Biologics Revenue Market Share by Country (2017-2028)
Figure 55. Germany Biosimilars/Follow-on-Biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. France Biosimilars/Follow-on-Biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. United Kingdom Biosimilars/Follow-on-Biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Russia Biosimilars/Follow-on-Biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Italy Biosimilars/Follow-on-Biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Asia-Pacific Biosimilars/Follow-on-Biologics Sales Market Share by Region (2017-2028)
Figure 61. Asia-Pacific Biosimilars/Follow-on-Biologics Sales Market Share by Application (2017-2028)
Figure 62. Asia-Pacific Biosimilars/Follow-on-Biologics Sales Market Share by Region (2017-2028)
Figure 63. Asia-Pacific Biosimilars/Follow-on-Biologics Revenue Market Share by Region (2017-2028)
Figure 64. China Biosimilars/Follow-on-Biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Japan Biosimilars/Follow-on-Biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Korea Biosimilars/Follow-on-Biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. India Biosimilars/Follow-on-Biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Southeast Asia Biosimilars/Follow-on-Biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Australia Biosimilars/Follow-on-Biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. South America Biosimilars/Follow-on-Biologics Sales Market Share by Type (2017-2028)
Figure 71. South America Biosimilars/Follow-on-Biologics Sales Market Share by Application (2017-2028)
Figure 72. South America Biosimilars/Follow-on-Biologics Sales Market Share by Country (2017-2028)
Figure 73. South America Biosimilars/Follow-on-Biologics Revenue Market Share by Country (2017-2028)
Figure 74. Brazil Biosimilars/Follow-on-Biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Argentina Biosimilars/Follow-on-Biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Middle East & Africa Biosimilars/Follow-on-Biologics Sales Market Share by Type (2017-2028)
Figure 77. Middle East & Africa Biosimilars/Follow-on-Biologics Sales Market Share by Application (2017-2028)
Figure 78. Middle East & Africa Biosimilars/Follow-on-Biologics Sales Market Share by Region (2017-2028)
Figure 79. Middle East & Africa Biosimilars/Follow-on-Biologics Revenue Market Share by Region (2017-2028)
Figure 80. Turkey Biosimilars/Follow-on-Biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Egypt Biosimilars/Follow-on-Biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. Saudi Arabia Biosimilars/Follow-on-Biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 83. South Africa Biosimilars/Follow-on-Biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 84. Manufacturing Cost Structure Analysis of Biosimilars/Follow-on-Biologics in 2021
Figure 85. Manufacturing Process Analysis of Biosimilars/Follow-on-Biologics
Figure 86. Biosimilars/Follow-on-Biologics Industrial Chain
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
Figure 88. Methodology
Figure 89. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
